MYL, AVNR and ACT -- Pre-Market Briefing
Note to Editors: The Following Is an Investment Opinion Being Issued by the WSA Financial Ltd.

LONDON -- (Marketwire) -- 02/20/13 -- The Dow Jones and the S&P 500 finished at multi-year highs on Tuesday. The Dow Jones closed 0.39% higher at 14,035.67, the S&P 500 closed 0.73% higher at 1,530.94, and the NASDAQ closed 0.68% higher at 3,213.59. At the close, our research team took notice of Mylan Inc. (NASDAQ: MYL), Avanir Pharmaceuticals (NASDAQ: AVNR) and Actavis Inc. (NYSE: ACT). Wall Street Active research team has completed free research on MYL, AVNR and ACT. As a leading provider of free in depth reports and timely market updates, we invite you to sign up now at

Mylan's Shares Slip

Mylan's shares fell on Tuesday, ending the day 0.38% lower at $29.11 on volume of 2.99 million. The stock rose to a 52-week high of $29.30 before paring its gains. The company's shares have had a decent run so far this year, gaining more than 6% as compared to a gain of around 6.4% for NASDAQ. Mylan's shares recently broke through $29 resistance level, which is a bullish signal. The bullish trend is further confirmed by the recent volume activity and its MACD chart. The stock's MACD is trading above the signal line and the zero-line. Mylan's share are trading above their 50-day and 200-day moving averages, which is another bullish signal. Sign up today and get useful insight about MYL for free at

Avanir Pharma's Shares Gain

Shares of Avanir Pharma, which is engaged in the development and commercialization of therapeutic products for the treatment of central nervous system disorders, rose sharply on Tuesday, ending the day 2.14% higher at $2.86 on volume of 1.07 million. The stock has had a decent run this year, gaining more than 9%. Avanir's shares are trading at their 50-day moving average and slightly below their 200-day moving average. The stock's MACD is currently trading below the signal line and the zero-line. The company's shares are currently facing resistance at around $3.20. The stock has support at $2.80. Free report on AVNR can be accessed by registering at

Actavis Shares End Marginally Lower

Actavis shares finished marginally lower on Tuesday. The stock closed 0.50% lower at $84.81 on above average volume of 2.06 million. Year-to-date, the company's shares have fallen more than 1.3%. The stock has been extremely volatile in recent weeks. It has been facing stiff resistance at around $88. Recent volume activity suggests that the market sentiment is bearish on the stock. The bearish trend is further confirmed by the MACD chart. The stock's MACD has just moved below the signal line and the zero-line. Register with Wall Street Active and download the research on ACT for free at

Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here